Bahou, PharmD, MBA. Bahou detailed that his approach to integrating biosimilars into his organization revolves around addressing the escalating costs of drugs compared with patient premiums.

With more biosimilar options available, we’ve seen a significant uptick in biosimilar market share. For example, Zarxio has captured more than 50% of market share in the Filgrastim market since ...

Amgen has reported positive phase 3 results with its biosimilar version of AstraZeneca/Alexion's blockbuster rare disease drug Soliris, setting up a regulatory filing with the FDA. The biotech has ...

In India, these drugs are underutilized due to high costs and limited awareness. Biosimilars offer a more affordable alternative. JAK inhibitors treat conditions like ankylosing spondylitis but ...

The best graphic design software gives you the tools you need to create eye-catching artwork, adverts, and modern masterpieces. From the best laptops for graphic design and the best monitors for ...

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday ...

After hours: September 19 at 7:53 PM EDT Loading Chart for QUAD ...

In my past stints at Forbes India, the Economic Times, Business Standard and Businessworld, I have written on technology, finance, management, and strategy. My colleague Pravin Palande and I won the ...

Sophia Humphreys, PharmD, MHA, BCBBS, director of system formulary management at Sutter Health, discusses the challenges of expanding biosimilars into new therapeutic areas and highlights the role of ...